<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">BR-20-5-01767</article-id>
<article-id pub-id-type="doi">10.3892/br.2024.1767</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rare histopathological finding of ovarian pseudotumor: A case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Samara</surname><given-names>Batool</given-names></name>
<xref rid="af1-BR-20-5-01767" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Shriam</surname><given-names>Suha</given-names></name>
<xref rid="af1-BR-20-5-01767" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Al-Balas</surname><given-names>Aseel</given-names></name>
<xref rid="af1-BR-20-5-01767" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Isied</surname><given-names>Reham</given-names></name>
<xref rid="af1-BR-20-5-01767" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Abu Mahfouz</surname><given-names>Ismaiel</given-names></name>
<xref rid="af2-BR-20-5-01767" ref-type="aff">2</xref>
<xref rid="c1-BR-20-5-01767" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Almasri</surname><given-names>Anwar</given-names></name>
<xref rid="af3-BR-20-5-01767" ref-type="aff">3</xref>
</contrib>
</contrib-group>
<aff id="af1-BR-20-5-01767"><label>1</label>Department of Obstetrics and Gynaecology, Specialty Hospital, Amman 11194, Jordan</aff>
<aff id="af2-BR-20-5-01767"><label>2</label>Department of Obstetrics and Gynaecology, Faculty of Medicine, Al-Balqa Applied University, Al Salt 19117, Jordan</aff>
<aff id="af3-BR-20-5-01767"><label>3</label>Department of Histopathology, Specialty Hospital, Amman 11194, Jordan</aff>
<author-notes>
<corresp id="c1-BR-20-5-01767"><italic>Correspondence to:</italic> Dr Ismaiel Abu Mahfouz, Department of Obstetrics and Gynaecology, Faculty of Medicine, Al Balqa Applied University, 60 Street, Al Salt 19117, Jordan <email>ismaiel.mahfouz@bau.edu.jo wangling2016uw@126.com </email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>05</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>03</month>
<year>2024</year></pub-date>
<volume>20</volume>
<issue>5</issue>
<elocation-id>79</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Samara et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>An inflammatory pseudotumor (IPT) is a benign, rare chronic inflammatory process that is destructive to normal histology of the involved organs. While IPT most frequently affects the lung and orbits, it can occur in almost any part of the body. Additionally, histopathological examination is often difficult to interpret, typically showing myofibroblasts and mixed inflammatory and spindle-shaped cells. The histopathological picture may resemble low grade fibrosarcoma with inflammatory cells, making the differentiation between benign and malignant diseases more difficult and potentially requiring specialized histopathological studies. In the present study, a 39-year-old healthy female patient with no history of sexual activity presented to The Specialty Hospital (Amman Jordan) in January 2023 with mild lower abdominal pain. A pelvic ultrasound scan showed a complex right ovarian cyst measuring 6.0x6.5 cm. Tumor markers were normal. The patient underwent laparotomy with an ovarian cystectomy and left ovarian, omental and peritoneal biopsies. The histopathology of the cyst was suggestive of IPT. Other histopathological results were normal. The patient was followed up for 1 year after surgery with no recurrence of the disease.</p>
</abstract>
<kwd-group>
<kwd>ovarian cyst</kwd>
<kwd>inflammatory pseudotumor</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>An inflammatory pseudotumor (IPT) is a benign, rare chronic inflammatory process that most frequently affects the lung and orbits as an extrapulmonary site but can occur in almost any organ in the body such as pelvic organs (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>). Its occurrence in the pelvis is rare with only two cases being reported (<xref rid="b2-BR-20-5-01767" ref-type="bibr">2</xref>,<xref rid="b3-BR-20-5-01767" ref-type="bibr">3</xref>). IPTs typically follow a benign clinical course, with 25&#x0025; rate of local recurrence (<xref rid="b4-BR-20-5-01767" ref-type="bibr">4</xref>). While IPT may occur in any age group, more than half of the cases occur in patients aged 30-49 years with peak age of 38.9 years and female predominance (<xref rid="b5-BR-20-5-01767" ref-type="bibr">5</xref>).</p>
<p>The origin of IPT is not known, but various mechanisms have been suggested including immune-autoimmune, trauma and surgical inflammation (<xref rid="b6-BR-20-5-01767" ref-type="bibr">6</xref>), furthermore, it may resemble low-grade fibrosarcoma with inflammatory cells (<xref rid="b6-BR-20-5-01767" ref-type="bibr">6</xref>).</p>
<p>IPT may develop as the result of an infection linked to different pathogens at different body sites, such as mycoplasmata and Nocardiae in the lungs, actinomycetes in the liver, Epstein-Barr virus in the spleen and mycobacteria in spindle cell tumors (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>). The diagnosis of IPT is difficult as it is typically made by exclusion based on the histopathological findings (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>). For the majority of IPT, the preferred treatment is surgical resection (<xref rid="b7-BR-20-5-01767" ref-type="bibr">7</xref>).</p>
</sec>
<sec sec-type="Case|report">
<title>Case report</title>
<p>A 39-year-old healthy female patient with hypothyroidism and no previous surgical operations or sexual activity presented to Dr Ismaiel Abu Mahfouz gynaecology clinic in The Specialty Hospital (Amman, Jordan) in January 2023 with mild lower abdominal pain. Ultrasound examination showed a complex right sided ovarian cyst measuring 6.0x6.5 cm. There was no evidence of free fluid in the pelvis, and the left ovary and uterus were unremarkable. Pelvic magnetic resonance imaging (MRI) and ovarian tumor marker assessment (cancer antigen 125 and 19-9, carcinoembryonic antigen, and beta subunit of human chorionic gonadotropin) was requested to rule out malignancy. MRI confirmed the presence of a complex cystic lesion mostly arising from the right ovary and extending posteriorly, measuring &#x007E;6.5x5.6 cm and having a thick nodular enhancing wall with thin enhancing septations. The uterus was of normal size with no focal lesion; no other solid masses could be seen in the pelvis and there was a small amount of free fluid seen in the pelvis and no recognized pelvic adenopathy (<xref rid="f1-BR-20-5-01767" ref-type="fig">Fig. 1</xref>).</p>
<p>Tumor markers showed CA-125 was 30 (normal range: 0-35 units/ml), cancer antigen 19-9 was 6 (normal range 0-37 units/ml), carcinoembryonic antigen was 0.9 (normal range 0-2.5 ng/ml), beta subunit of human chorionic gonadotropin was negative and lactate Dehydrogenase was 27 (normal range 105-333 IU/L) (<xref rid="b8-BR-20-5-01767" ref-type="bibr">8</xref>).</p>
<p>Considering the complex nature of the cyst and after counselling, a low transverse laparotomy was performed in January 2023 at The Specialty Hospital, Amman Jordan. The findings during laparotomy showed a right ovarian mass measuring &#x007E;7x8 cm (<xref rid="f2-BR-20-5-01767" ref-type="fig">Fig. 2</xref>). The uterus and left ovary looked normal and there was a small amount of serous free fluid in the pelvis. The peritoneal fluid was aspirated, and a right ovarian cystectomy was performed along with left ovarian, peritoneal and omental biopsies.</p>
<p>The histopathology techniques were as follows: Dehydration by ethanol from 70 to 100&#x0025;, Clearing by xylene, Impregnation using wax 52-56&#x02DA;C. Paraffin embedding was at 65&#x02DA;C for 16 h A section Thickness was 5 micron. BenchMark GX, VENTANA) with ready-to-use made antibodies was used for antibody dilution. For detection and counter-stain hematoxylin was used and viewed under a light microscope.</p>
<p>The histopathology of the right ovarian cyst showed fibrovascular core (hemangiopericytoma-like) infiltrate by mononuclear chronic inflammatory cells with histiocytes and numerous multinucleated giant cells. The infiltrate was in a diffuse pattern with perivascular cuffing, myxoid degeneration, fibrinoid material and hyalinized fibrosis (<xref rid="f3-BR-20-5-01767" ref-type="fig">Fig. 3</xref>).</p>
<p>The lesion was immunoreactive for vimentin (<xref rid="f4-BR-20-5-01767" ref-type="fig">Fig. 4</xref>) but not reactive for actin (<xref rid="f5-BR-20-5-01767" ref-type="fig">Fig. 5</xref>), positively stained for S100 (<xref rid="f6-BR-20-5-01767" ref-type="fig">Fig. 6</xref>), CD34 (<xref rid="f7-BR-20-5-01767" ref-type="fig">Fig. 7</xref>) and CD68 (<xref rid="f8-BR-20-5-01767" ref-type="fig">Fig. 8</xref>), highlighting the histiocytes. Ki-67 proliferating index was high &#x003E;20&#x0025; (<xref rid="f9-BR-20-5-01767" ref-type="fig">Fig. 9</xref>). The overall pathology and immune results indicated IPT. While the results of peritoneal fluid cytology was negative for malignant cells; there were hyperplastic mesothelial cells and macrophages with rare inflammatory exudate. Additionally, peritoneal and omental biopsies were normal. The patient was uneventfully followed up till September 2023.</p>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>IPT is rarely seen in the pelvis. To the best of our knowledge, there are few reported cases of IPT affecting the female reproductive system (<xref rid="b2-BR-20-5-01767" ref-type="bibr">2</xref>,<xref rid="b9-BR-20-5-01767" ref-type="bibr">9</xref>). The patient in our case report was found to have ovarian inflammatory pseudotumor.</p>
<p>Here, the patient presented with mild lower abdominal pain and was diagnosed with IPT. Patients in these cases may present with symptoms associated with mass effect or with non-specific symptoms and signs of inflammation such as fever, weight loss, and abdominal pain (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>).</p>
<p>There are no specific characteristic features for IPT on imaging studies (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>). The present MRI findings showed features of a complex cystic ovarian tumor with a thick wall and enhancing septation, which were non-specific (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>,<xref rid="b7-BR-20-5-01767" ref-type="bibr">7</xref>). The lack of specific radiological characteristics may be related to the degree of fibrosis and cellular infiltration, where lesions may seem hypoechoic or hyperechoic with ill-defined or well-circumscribed boundaries on ultrasound images. These lesions frequently have more vascularity in the Doppler test (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>).</p>
<p>A homogenous or heterogeneous lesion may be visible on contrast-enhanced MRI scan, and in the presence of fibrosis, more enhancement may be demonstrated with delayed MRI images (<xref rid="b1-BR-20-5-01767" ref-type="bibr">1</xref>). Diagnosis of IPT depends on histopathological studies, which may show myofibroblasts and mixed inflammatory and spindle-shaped cells (plasma cells, lymphocytes and, sporadically, histiocytes) (<xref rid="b10-BR-20-5-01767" ref-type="bibr">10</xref>). Furthermore, IPT may be misdiagnosed as low-grade fibrosarcoma. Histopathological features differentiating these are seen in low grade fibrosarcoma and include the presence of atypia (<xref rid="b3-BR-20-5-01767" ref-type="bibr">3</xref>,<xref rid="b11-BR-20-5-01767" ref-type="bibr">11</xref>). Here, immunostaining for vimentin was positive and negative for actin and the Ki 67 proliferation index was 20&#x0025; (<xref rid="b11-BR-20-5-01767" ref-type="bibr">11</xref>). The IPT was surgically removed for both diagnosis and treatment. The prognosis of the disease is still unknown and there is risk of recurrence (<xref rid="b2-BR-20-5-01767" ref-type="bibr">2</xref>,<xref rid="b12-BR-20-5-01767" ref-type="bibr">12</xref>).</p>
<p>In conclusion, IPT can arise from the ovary, with no pathognomonic features on the imaging. In addition, it is rare and may not be easily diagnosed on histopathological studies as it may resemble low grade fibrosarcoma. Surgical resection is the most common therapy.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study are included in the figures and/or tables of this article.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>BS, SS, AAB, RI, AA and IAM performed clinical management and surgery. AAB and RI collected clinical data, edited the manuscript and constructed figures. AA performed histopathological experiments and wrote the manuscript. IAM and AA confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-BR-20-5-01767"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patnana</surname><given-names>M</given-names></name><name><surname>Sevrukov</surname><given-names>AB</given-names></name><name><surname>Elsayes</surname><given-names>KM</given-names></name><name><surname>Viswanathan</surname><given-names>C</given-names></name><name><surname>Lubner</surname><given-names>M</given-names></name><name><surname>Menias</surname><given-names>CO</given-names></name></person-group><article-title>Inflammatory pseudotumor: The great mimicker</article-title><source>AJR Am J Roentgenol</source><volume>198</volume><fpage>W217</fpage><lpage>W227</lpage><year>2012</year><pub-id pub-id-type="pmid">22358018</pub-id><pub-id pub-id-type="doi">10.2214/AJR.11.7288</pub-id></element-citation></ref>
<ref id="b2-BR-20-5-01767"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolnicu</surname><given-names>S</given-names></name><name><surname>Soslow</surname><given-names>RA</given-names></name></person-group><article-title>Inflammatory pseudotumor presenting as a mesosalpingeal mass</article-title><source>Int J Gynecol Pathol</source><volume>37</volume><fpage>473</fpage><lpage>476</lpage><year>2018</year><pub-id pub-id-type="pmid">28863066</pub-id><pub-id pub-id-type="doi">10.1097/PGP.0000000000000434</pub-id></element-citation></ref>
<ref id="b3-BR-20-5-01767"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>TT</given-names></name><name><surname>Cheng</surname><given-names>NH</given-names></name><name><surname>Cao</surname><given-names>DY</given-names></name><name><surname>Peng</surname><given-names>P</given-names></name></person-group><article-title>Ovarian fibrosarcoma: A single-institution experience and a review of the literature</article-title><source>J Ovarian Res</source><volume>13</volume><issue>142</issue><year>2020</year><pub-id pub-id-type="pmid">33292402</pub-id><pub-id pub-id-type="doi">10.1186/s13048-020-00749-x</pub-id></element-citation></ref>
<ref id="b4-BR-20-5-01767"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gude</surname><given-names>D</given-names></name><name><surname>Rayudu</surname><given-names>R</given-names></name><name><surname>Bansal</surname><given-names>D</given-names></name></person-group><article-title>How pseudo is an inflammatory pseudotumor?</article-title><source>Indian J Med Paediatr Oncol</source><volume>32</volume><fpage>204</fpage><lpage>206</lpage><year>2011</year><pub-id pub-id-type="pmid">22563153</pub-id><pub-id pub-id-type="doi">10.4103/0971-5851.95141</pub-id></element-citation></ref>
<ref id="b5-BR-20-5-01767"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajani</surname><given-names>MA</given-names></name><name><surname>Fatunla</surname><given-names>EO</given-names></name><name><surname>Onakpoma</surname><given-names>FA</given-names></name><name><surname>Salami</surname><given-names>AA</given-names></name></person-group><article-title>Inflammatory Pseudotumor: A 20-year single institutional experience</article-title><source>Adv Biomed Res</source><volume>9</volume><issue>68</issue><year>2020</year><pub-id pub-id-type="pmid">33816387</pub-id><pub-id pub-id-type="doi">10.4103/abr.abr_48_20</pub-id></element-citation></ref>
<ref id="b6-BR-20-5-01767"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fayad</surname><given-names>FT</given-names></name><name><surname>Bezerra</surname><given-names>MCT</given-names></name><name><surname>da Rosa</surname><given-names>MRP</given-names></name><name><surname>Pinheiro</surname><given-names>TN</given-names></name></person-group><article-title>Diagnosis, treatment, and rehabilitation of a patient with inflammatory pseudotumor</article-title><source>Eur J Dent</source><volume>12</volume><fpage>454</fpage><lpage>458</lpage><year>2018</year><pub-id pub-id-type="pmid">30147417</pub-id><pub-id pub-id-type="doi">10.4103/ejd.ejd_333_17</pub-id></element-citation></ref>
<ref id="b7-BR-20-5-01767"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedlic</surname><given-names>T</given-names></name><name><surname>Scali</surname><given-names>EP</given-names></name><name><surname>Lee</surname><given-names>WK</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>SD</given-names></name></person-group><article-title>Inflammatory Pseudotumours in the Abdomen and Pelvis: A pictorial essay</article-title><source>Can Assoc Radiol J</source><volume>65</volume><fpage>52</fpage><lpage>59</lpage><year>2014</year><pub-id pub-id-type="pmid">23830343</pub-id><pub-id pub-id-type="doi">10.1016/j.carj.2013.02.003</pub-id></element-citation></ref>
<ref id="b8-BR-20-5-01767"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>GL</given-names></name><name><surname>Slater</surname><given-names>ED</given-names></name><name><surname>Sanders</surname><given-names>GK</given-names></name><name><surname>Prichard</surname><given-names>JG</given-names></name></person-group><article-title>Serum tumor markers</article-title><source>Am Fam Physician</source><volume>68</volume><fpage>1075</fpage><lpage>1082</lpage><year>2003</year><pub-id pub-id-type="pmid">14524394</pub-id></element-citation></ref>
<ref id="b9-BR-20-5-01767"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x00FC;cer</surname><given-names>F</given-names></name><name><surname>Altaner</surname><given-names>S</given-names></name><name><surname>M&#x00FC;layim</surname><given-names>N</given-names></name><name><surname>Yapicier</surname><given-names>O</given-names></name></person-group><article-title>Invasive inflammatory pseudotumor of uterine cervix: A case report</article-title><source>Gynecol Oncol</source><volume>98</volume><fpage>325</fpage><lpage>328</lpage><year>2005</year><pub-id pub-id-type="pmid">15975639</pub-id><pub-id pub-id-type="doi">10.1016/j.ygyno.2005.05.021</pub-id></element-citation></ref>
<ref id="b10-BR-20-5-01767"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntinas</surname><given-names>A</given-names></name><name><surname>Kardassis</surname><given-names>D</given-names></name><name><surname>Miliaras</surname><given-names>D</given-names></name><name><surname>Tsinoglou</surname><given-names>K</given-names></name><name><surname>Dimitriades</surname><given-names>A</given-names></name><name><surname>Vrochides</surname><given-names>D</given-names></name></person-group><article-title>Inflammatory pseudotumor of the liver: A case report and review of the literature</article-title><source>J Med Case Rep</source><volume>5</volume><issue>196</issue><year>2011</year><pub-id pub-id-type="pmid">21600001</pub-id><pub-id pub-id-type="doi">10.1186/1752-1947-5-196</pub-id></element-citation></ref>
<ref id="b11-BR-20-5-01767"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gultekin</surname><given-names>M</given-names></name><name><surname>Dursun</surname><given-names>P</given-names></name><name><surname>Ozyuncu</surname><given-names>O</given-names></name><name><surname>Usubutun</surname><given-names>A</given-names></name><name><surname>Yuce</surname><given-names>K</given-names></name><name><surname>Ayhan</surname><given-names>A</given-names></name></person-group><article-title>Primary ovarian fibrosarcoma: A case report and review of the literature</article-title><source>Int J Gynecol Cancer</source><volume>15</volume><fpage>1142</fpage><lpage>1147</lpage><year>2005</year><pub-id pub-id-type="pmid">16343198</pub-id><pub-id pub-id-type="doi">10.1111/j.1525-1438.2005.00327.x</pub-id></element-citation></ref>
<ref id="b12-BR-20-5-01767"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Akanabe</surname><given-names>K</given-names></name><name><surname>Maeshima</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>R</given-names></name></person-group><article-title>Surgery for recurrent inflammatory pseudotumor of the lung</article-title><source>World J Surg Oncol</source><volume>9</volume><issue>133</issue><year>2011</year><pub-id pub-id-type="pmid">22004917</pub-id><pub-id pub-id-type="doi">10.1186/1477-7819-9-133</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-BR-20-5-01767" position="float">
<label>Figure 1</label>
<caption><p>Magnetic resonance imaging of complex cystic lesion (arrow) mostly arising from the right ovary and extending posteriorly measuring &#x007E;6.5x5.6 cm and having a thick nodular enhancing wall with thin enhancing septations.</p></caption>
<graphic xlink:href="br-20-05-01767-g00.tif" />
</fig>
<fig id="f2-BR-20-5-01767" position="float">
<label>Figure 2</label>
<caption><p>Gross appearance of right ovarian mass intraoperatively.</p></caption>
<graphic xlink:href="br-20-05-01767-g01.tif" />
</fig>
<fig id="f3-BR-20-5-01767" position="float">
<label>Figure 3</label>
<caption><p>Histopathology of the right ovarian cyst showing infiltrate by mononuclear chronic inflammatory cells with histiocytes and numerous multinucleated giant cells. Right image magnification, x40; left image magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g02.tif" />
</fig>
<fig id="f4-BR-20-5-01767" position="float">
<label>Figure 4</label>
<caption><p>Positive vimentin staining (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g03.tif" />
</fig>
<fig id="f5-BR-20-5-01767" position="float">
<label>Figure 5</label>
<caption><p>Negative actin staining (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g04.tif" />
</fig>
<fig id="f6-BR-20-5-01767" position="float">
<label>Figure 6</label>
<caption><p>Positive S100 staining (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g05.tif" />
</fig>
<fig id="f7-BR-20-5-01767" position="float">
<label>Figure 7</label>
<caption><p>Positive CD34 staining (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g06.tif" />
</fig>
<fig id="f8-BR-20-5-01767" position="float">
<label>Figure 8</label>
<caption><p>Positive CD68 staining (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g07.tif" />
</fig>
<fig id="f9-BR-20-5-01767" position="float">
<label>Figure 9</label>
<caption><p>Ki-67 proliferating index (magnification, x100).</p></caption>
<graphic xlink:href="br-20-05-01767-g08.tif" />
</fig>
</floats-group>
</article>
